Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

231.92 +3.74 (+1.64%)

Official Closing Price Updated: 7:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Expert Ratings for IQVIA Hldgs ↗

December 06, 2022

Via Benzinga

Veracyte Stock Showing Market Leadership; Earns 93 RS Rating ↗

December 01, 2022

Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

Where IQVIA Hldgs Stands With Analysts ↗

November 17, 2022

Via Benzinga

Analyst Ratings for IQVIA Hldgs ↗

November 17, 2022

Via Benzinga

8 Analysts Have This to Say About IQVIA Hldgs ↗

October 27, 2022

IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter:

Via Benzinga

7 Analysts Have This to Say About IQVIA Hldgs ↗

October 06, 2022

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:

Via Benzinga

Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings ↗

November 17, 2022

Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.

Via Benzinga

IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel

November 10, 2022

From IQVIA

Via Business Wire

General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday ↗

October 27, 2022

Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%...

Via Benzinga

IQVIA: Q3 Earnings Insights ↗

October 26, 2022

IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated...

Via Benzinga

Expert Ratings for IQVIA Hldgs ↗

September 12, 2022

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:

Via Benzinga

6 Analysts Have This to Say About IQVIA Hldgs ↗

September 12, 2022

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:

Via Benzinga

What 5 Analyst Ratings Have To Say About IQVIA Hldgs ↗

August 25, 2022

Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:

Via Benzinga

IQVIA Reports Third-Quarter 2022 Results

October 26, 2022

From IQVIA Holdings Inc.

Via Business Wire

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

October 25, 2022

Via The Motley Fool

IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022

October 24, 2022

From IQVIA Holdings Inc.

Via Business Wire

Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso

October 06, 2022

From IQVIA

Via Business Wire

5 Analysts Have This to Say About IQVIA Hldgs ↗

August 25, 2022

Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:

Via Benzinga

Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67% ↗

October 06, 2022

HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.

Via Benzinga

IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022

October 03, 2022

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation

September 28, 2022

From IQVIA

Via Business Wire

New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials

September 07, 2022

From IQVIA

Via Business Wire

IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022

September 02, 2022

From IQVIA

Via Business Wire

IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference on September 13, 2022

September 01, 2022

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Wins Snowflake’s “Marketplace Healthcare and Life Sciences Partner of the Year” Award

August 15, 2022

From IQVIA

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Peering Into IQVIA's Recent Short Interest ↗

August 11, 2022

IQVIA Hldgs (NYSE:IQV) short percent of float has fallen 20.35% since its last report. The company recently reported that it has 1.67 million shares sold short, which...

Via Benzinga

7 Growth Stocks to Buy on the Dip ↗

July 22, 2022

These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

IQVIA Holdings, Inc. Common Stock (NY:IQV)

All News about IQVIA Holdings, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today